Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Olga Karpov"'
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 12872
Early detection of tumor cells by identifying universal Tumor Associated Antigens (TAA) can drastically change our diagnostic, theranostic and therapeutic possibilities to cure cancer. Human Telomerase Reverse Transcriptase (hTERT), a hallmark of can
Autor:
Olga Karpov, Yael Barhum, Shlomo Bulvik, Yossef S. Levy, Merav Bahat-Stroomza, Daniel Offen, Eldad Melamed
Publikováno v:
Journal of molecular neuroscience : MN. 39(1-2)
Parkinson's disease (PD) is a neurodegenerative disorder with its motor phenomena due mostly to loss of dopamine-producing neurons in the substantia nigra. Pharmacological treatments aimed to increase the deficient dopaminergic neurotransmission are
Autor:
Chaim Gilon, Moshe Bracha, Sharon Gazal, Olga Karpov, Ofer Ziv, Michel Afargan, Garry Gelerman, Pninit Litman
Publikováno v:
Journal of medicinal chemistry. 45(8)
Somatostatin-14 (somatostatin) and its clinically available analogues octreotide, lanreotide, and vapreotide are potent inhibitors of growth hormone, insulin, and glucagon release. Recently, a novel backbone cyclic somatostatin analogue c(GABA-Phe-Tr
Autor:
Olga Karpov, Gary Gelerman, Sharon Gazal, Chaim Gilon, Moshe Bracha, Michael Afargan, Pninit Litman, Ofer Ziv, Shaokai Jiang, Murray Goodman
Publikováno v:
Journal of peptide science : an official publication of the European Peptide Society. 7(10)
A cyclic somatostatin analog (1) has been synthesized. Biological assays show that this compound has strong binding affinities to somatostatin hsst2 and hsst5 receptor subtypes (5.2 and 1.2 nM, respectively, and modest affinity to hsst4 (41.1 nM)). O
Autor:
Offer Ziv, Michel Afargan, Rakefet Rosenfeld, David Stephensky, Dvira Shohat, Moshe Bracha, George Liapakis, Amnon Hoffman, Olga Karpov, Garry Gelerman, Amnon Wolf, Eva Tiensuu Janson, Kjell Öberg, Chaim Gilon
Publikováno v:
Endocrinology. 142(1)
Somatostatin, also known as somatotropin release-inhibiting factor (SRIF), is a natural cyclic peptide inhibitor of pituitary, pancreatic, and gastrointestinal secretion. Its long-acting analogs are in clinical use for treatment of various endocrine
Autor:
Sharon Gazal, Gary Gellerman, Ofer Ziv, Olga Karpov, Pninit Litman, Moshe Bracha, Michel Afargan, Chaim Gilon
Publikováno v:
Peptides: The Wave of the Future ISBN: 9789401039055
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85e0e80fd4b9acefa281fb9089ba69f9
https://doi.org/10.1007/978-94-010-0464-0_291
https://doi.org/10.1007/978-94-010-0464-0_291
Autor:
Offer Ziv, Michel Afargan, Rakefet Rosenfeld, Eva Tiensuu Janson, Olga Karpov, Garry Gelerman, Kjell Öberg, Moshe Bracha
Publikováno v:
Regulatory Peptides. 94:74
Autor:
Karpov, Olga1 (AUTHOR), Lahav, Meir2,3,4 (AUTHOR), Wolach, Ofir3,4 (AUTHOR), Raanani, Pia2,3,4 (AUTHOR), Peer, Dan1 (AUTHOR), Kaplan, Tal5 (AUTHOR), Uziel, Orit2,3,4 (AUTHOR) oritu@clalit.org.il
Publikováno v:
International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 21, p12872. 14p.
Publikováno v:
Gene Therapy Weekly; 12/26/2024, p3334-3334, 1p
Autor:
Bahat-Stroomza, Merav, Barhum, Yael, Levy, Yossef, Karpov, Olga, Bulvik, Shlomo, Melamed, Eldad, Offen, Daniel
Publikováno v:
Journal of Molecular Neuroscience; Sep2009, Vol. 39 Issue 1/2, p199-210, 12p